IRCT20121028011288N18招募中3 期
The effect of ellagic acid supplementation on glycemic indices, lipid profile, anthropometric, inflammatory and oxidative indices, dietary intake and serum levels of pentosidine, adiponectin and resistin in patients with types 2: a double-blind, randomized controlled clinical trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 46
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 years 至 60 years（—）
- 性别
- All
入选标准
- •patients with type 2 diabetes
- •Using blood sugar lowering medicine
- •Age range of 30-60 years
- •BMI in the range of 25-35
- •1 to 15 years duration of type 2 diabetes
- •Tendecy of corporation
排除标准
- •Use of corticosteroids, steroidal and non-steroidal anti-inflammatory drugs
- •Prescribing insulin
- •Suffering from chronic diseases such as heart failure, kidney, liver and thyroid disorders
研究者
相似试验
招募中
3 期
Ellagic acid and type 2 diabetesType 2 diabetes.Type 2 diabetesIRCT20210219050412N1Bagheiat-allah University of Medical Sciences60
招募中
3 期
Ellagic acid supplementation effect in patients with Major DepressiveMajor depressive episode.Major depressive disorder, single episodeIRCT20141025019669N15Mazandaran University of Medical Sciences60
招募中
3 期
Ellagic acid supplementation in patients with non-alcoholic fatty liver diseaseon alcoholic fatty liver disease.Other specified inflammatory liver diseasesK75.8IRCT20141025019669N21Qazvin University of Medical Sciences44
已完成
3 期
Ellagic acid supplementation in patient with irritabe bowel syndromeIrritable bowel syndrome.K58.0Irritable bowel syndrome with diarrheaIRCT20141025019669N11Qazvin University of Medical Sciences44
已完成
3 期
Ellagic acid supplementation in women with the poly cystic ovarian syndromePolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2IRCT20141025019669N12Qazvin University of Medical Sciences60